Results 1 to 10 of about 1,174,939 (305)

Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study

Pneumonia, 2022
Background Community-acquired pneumonia (CAP) is the most common cause of acute respiratory distress syndrome (ARDS). Although previous studies have suggested that macrolide therapy is beneficial for ARDS, its benefit for severe CAP-associated ARDS ...
Jun Suzuki, Yusuke Sasabuchi, Shuji Hatakeyama, Hiroki Matsui, Teppei Sasahara, Yuji Morisawa, Toshiyuki Yamada, Kiyohide Fushimi, Hideo Yasunaga   +8 more
doaj   +1 more source

Clinical features and prognosis of severe legionnaires’ disease requiring intensive care unit admission: a multicentric retrospective cohort study

Pneumonia
Introduction Legionella is the second cause of community-acquired pneumonia in Intensive Care Unit (ICU) patients. The aim of this study was to describe the epidemiology and outcome in patients with Legionella pneumonia (LP) in French ICUs.
Anaïs Dartevel, Louis-Marie Galerneau, Vincent Peigne, Nicholas Sedillot, Stephan Ehrmann, Alexandre Lautrette, Kada Klouche, Julien Poissy, Guillaume Thiery, Bertrand Sauneuf, Jean-Philippe Rigaud, Michel Ramakers, Cédric Daubin, Carole Schwebel, Nicolas Terzi   +14 more
doaj   +1 more source

Malawian children with fast-breathing pneumonia with and without comorbidities

Pneumonia, 2021
Background Due to high risk of mortality, children with comorbidities are typically excluded from trials evaluating pneumonia treatment. Understanding heterogeneity of outcomes among children with pneumonia and comorbidities is critical to ensuring ...
Amy Sarah Ginsburg, Tisungane Mvalo, Jun Hwang, Melda Phiri, Eric D. McCollum, Madalitso Maliwichi, Robert Schmicker, Ajib Phiri, Norman Lufesi, Susanne May   +9 more
doaj   +1 more source

Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilation

Pneumonia
Objetives To ascertain the role of the lung microbiome in the development of severe pneumonia and its potential as a biomarker for disease progression. Methods BAL samples from 34 adults with severe community-acquired pneumonia (CAP) (17 viral, 8 viral ...
Loreto Vidaur, Amalur Guridi, Oihana Leizaola, Jokin Marin, Jordi Rello, Cristina Sarasqueta, Ane Sorarrain, Jose María Marimón   +7 more
doaj   +1 more source

Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia

Pneumonia, 2018
Background Indigenous children in Australia’s Northern Territory are densely colonised with the pneumococcus within weeks of birth antecedent to a high prevalence of acute lower respiratory infection (ALRI).
Michael J. Binks, Sarah A. Moberley, Anne Balloch, Amanda J. Leach, Sandra Nelson, Kim M. Hare, Cate Wilson, Jane Nelson, Peter S. Morris, Robert S. Ware, Mimi L. K. Tang, Paul J. Torzillo, Jonathan R. Carapetis, Kim Mulholland, Ross M. Andrews   +14 more
doaj   +1 more source

Candida species in community-acquired pneumonia in patients with chronic aspiration

Pneumonia, 2021
Background When Candida species is found in a sputum culture, clinicians generally dismiss it as a contaminant. We sought to identify cases of community-acquired pneumonia (CAP) in which Candida might play a contributory etiologic role.
Benjamin J. Moss, Daniel M. Musher
doaj   +1 more source

Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study

Pneumonia, 2018
Background Streptococcus pneumoniae (SP) is one of the most common pathogens of Community-Acquired Pneumonia (CAP), but recent reports suggest that its incidence may be declining in relation to the use of the conjugate 13-valent pneumococcal vaccine in ...
Carlos M. Luna, Laura Pulido, Michael S. Niederman, Alberto Casey, Diego Burgos, Sebastián D. Leiva Agüero, Alejandra Grosso, Evangelina Membriani, Andrea C. Entrocassi, Marcelo Rodríquez Fermepin, Carlos A. Vay, Susana Garcia, Angela Famiglietti   +12 more
doaj   +1 more source

Pneumonia in Bhutanese children: what we know, and what we need to know

Pneumonia, 2020
Background Pneumonia is the single largest cause of death in under-five children worldwide. We conducted a systematic review to identify the knowledge gaps around childhood pneumonia in Bhutan. Methods We searched PubMed, ScienceDirect and Google scholar
Sophie Jullien, Dinesh Pradhan, Quique Bassat   +2 more
doaj   +1 more source

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England

Pneumonia, 2023
Background Pneumococcal disease is a leading cause of communicable disease morbidity and mortality globally. We aimed to estimate invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and all-cause pneumonia (ACP) incidence rates (IRs) in ...
Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Ian Matthews, Eric Sarpong, Alessandra Lacetera, Nawab Qizilbash   +6 more
doaj   +1 more source

Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children - are we there yet? A systematic review of randomised controlled trials

Pneumonia, 2014
Context: The ideal duration of antibiotic treatment for childhood community acquired pneumonia (CAP) has not yet been established. Objective: A literature search was conducted to evaluate the efficacy of shorter than 7 days duration of oral antibiotic ...
Shalom Ben-Shimol, Varda Levy-Litan, Oana Falup-Pecurariu, David Greenberg   +3 more
doaj   +1 more source